CAS 223673-61-8

Mirabegron

Descrizione:

Mirabegron è un composto farmaceutico utilizzato principalmente come medicinale per il trattamento della vescica iperattiva. Funziona come un agonista selettivo dei recettori adrenergici beta-3, il che significa che stimola i recettori adrenergici beta-3 nella vescica, portando al rilassamento del muscolo detrusore e all'aumento della capacità della vescica. Questo meccanismo aiuta ad alleviare sintomi come urgenza e frequenza urinaria. Mirabegron è caratterizzato dalla sua moderata lipofilia, che influisce sulla sua assorbimento e distribuzione nel corpo. Il composto ha una formula molecolare che riflette la sua struttura complessa, inclusi vari gruppi funzionali che contribuiscono alla sua attività farmacologica. Viene tipicamente somministrato per via orale e ha una emivita relativamente lunga, consentendo una somministrazione una volta al giorno. Gli effetti collaterali comuni possono includere ipertensione, infezioni del tratto urinario e mal di testa. In generale, Mirabegron rappresenta un significativo progresso nella gestione delle condizioni urinarie, fornendo un'alternativa ai farmaci anticolinergici.

Formula: C₂₁H₂₄N₄O₂S

InChI: InChI=1/C21H24N4O2S/c22-21-25-18(14-28-21)12-20(27)24-17-8-6-15(7-9-17)10-11-23-13-19(26)16-4-2-1-3-5-16/h1-9,14,19,23,26H,10-13H2,(H2,22,25)(H,24,27)

InChI key: InChIKey=PBAPPPCECJKMCM-IBGZPJMESA-N

SMILES: N(C(CC1=CSC(N)=N1)=O)C2=CC=C(CCNC[C@H](O)C3=CC=CC=C3)C=C2

Sinonimi:

• (R)-Mirabegron
• 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-[2-[((2R)-2-hydroxy-2-phenylethyl)amino]ethyl]phenyl]acetamide
• 2-(2-amino-1,3-thiazol-4-yl)-N-(4-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}phenyl)acetamide
• 2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-4-thiazoleacetamide
• 4-Thiazoleacetamide, 2-amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylethyl]amino]ethyl]phenyl]-
• Betanis
• Betmiga
• Mira veron
• Myrbetriq
• N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)-2-(2-aminothiazol-4-yl)acetamide
• Ym 178
• Mirabegron
• Merariveron impurity B
• Mirabegron(YM 178)
• (R)-2-(2-aminothiazol-4-yl)-N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl)acetamide
• hot selling Mirabegron
• Mirabello
• Mirabegron USP/EP/BP
• Mirabegron Intermediates
• 2-(2-Amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy2-phenylethyl]amino}ethyl)phenyl]acetamide
• Mirabelon
• CS-732
• (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide
• MIRABEQRON
• (2R)-2-(2-AMinothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)aMino]ethyl]acetic Acid Anilide
• Mirabegron, >=99%
• 2-AMino-N-[4-[2-[[(2R)-2-hydroxy-2-phenyl-ethyl]aMino]-ethyl]phenyl]-4-thiazoleacetaMide

Mirabegron

CAS: 223673-61-8

Mirabegron

Formula: C₂₁H₂₄N₄O₂S

Purezza: 99.9%

Colore e forma: White

Peso molecolare: 396.162

Ref: 47-1313

MIRABEGRON CRS

CAS: 223673-61-8

MIRABEGRON CRS

Ref: 41-Y0002371

Mirabegron

CAS: 223673-61-8

Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure

Formula: C₂₁H₂₄N₄O₂S

Colore e forma: White Off-White Brownish Yellow Crystalline Powder

Peso molecolare: 396.162

Ref: 45-1444106

Mirabegron

CAS: 223673-61-8

Mirabegron (YM178) is a beta-3 adrenergic agonist that is used for treatment of overactive bladder syndrome.

Formula: C₂₁H₂₄N₄O₂S

Purezza: 99.64%

Colore e forma: Light Yellow To Yellow Solid

Peso molecolare: 396.51

Ref: TM-T1671

2-(2-amino-1,3-thiazol-4-yl)-N-[4-(2-{[(2R)-2-hydroxy-2-phenylethyl]amino}ethyl)phenyl]acetamide

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Purezza: 97%

Colore e forma: Solid

Peso molecolare: 396.5059

Ref: IN-DA0037SU

Mirabegron

CAS: 223673-61-8

Mirabegron

Purezza: ≥98%

Peso molecolare: 396.51g/mol

Ref: 54-BUP12771

Mirabegron

CAS: 223673-61-8

Mirabegron

Purezza: 98%

Peso molecolare: 396.506g/mol

Ref: 54-OR1027819

Mirabegron

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Colore e forma: Pale Yellow Solid

Peso molecolare: 396.51

Ref: 4Z-M-861

Mirabegron

CAS: 223673-61-8

Colore e forma: Neat

Ref: 86-MM3776.00

Mirabegron

Prodotto controllato

CAS: 223673-61-8

Formula: C₂₁H₂₄N₄O₂S

Colore e forma: White

Peso molecolare: 396.51

Ref: TR-M364900

Mirabegron

CAS: 223673-61-8

Mirabegron is a drug that is used for the treatment of urinary incontinence and overactive bladder. It is a selective beta 3 adrenergic receptor agonist that has been shown to increase detrusor muscle contractility, thereby improving the storage capacity of the bladder. Mirabegron also decreases post-voiding residual volume and increases total voided volume. Mirabegron acts by binding to its receptor in adipose tissue, which leads to increased lipolysis and reduced appetite. The effect on lipolysis may be due to mirabegron's ability to inhibit DPP-IV activity.

Formula: C₂₁H₂₄N₄O₂S

Purezza: Min. 95 Area-%

Colore e forma: White Off-White Powder

Peso molecolare: 396.51 g/mol

Ref: 3D-FM26011